Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one ...

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with a high unmet medical need, today announced two important ...

The following is a summary of "Controversial Role Of Cd151 In Different Solid Tumors: Promoter Or Suppressor?,” published in ...

Is this growing wellness trend the holy grail of holistic health remedies, or is it a scam? I took a deep dive to find out.

Existing treatments for endometriosis have changed little in the past 30 years and are often ineffective or have undesired ...

Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET. Company Participants. Douglas Onsi - President ...

Scientists from Tomsk Polytechnic University, in collaboration with an interdisciplinary research team, are currently ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Effie has received several awards, including the NIH Director’s New Innovator award and the Emerging Leader Award from the Mark Foundation. She is currently a member of the 4D Nucleome Consortium.

2 Center of Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Objectives Erythropoietin (EPO), which is ...